AR
Anna RANDI
Description
Anna Randi is Professor of Cardiovascular Medicine at the National Heart and Lung Institute, Imperial College London. Her research interests are in vascular biology and haemostasis. The Randi lab has defined transcriptional and epigenetic mechanisms that control endothelial cell homeostasis and resilience in health and disease and identified of von Willebrand factor as a regulator of angiogenesis. The lab pioneered the study of circulating endothelial cells from patients’ blood (ECFC) to define disease mechanisms in von Willebrand disease and cardiovascular diseases.
Anna Randi is a clinically qualified haematologist. She studied Medicine at the University of Milan (Italy), and trained at Washington University, St. Louis (USA) and the Imperial Cancer research Uk (now Crick). In 2003, she set up her laboratory at Imperial College London where she has been ever since. From 2018 to 2025, she was Head of the Vascular Science Section.
Anna is actively involved in the vascular biology and homeostasis communities and has covered several roles in international organisations (including European Vascular Biology Organisation (EVBO), American Heart Association (AHA) and International Society of Thrombosis and Haemostasis (ISTH). Anna is committed to promoting the careers of young researchers, providing a supportive and stimulating training and working environment, with a particular focus on gender equality.
Loading